• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对不稳定型冠状动脉疾病病理生理学的见解

Insights into the pathophysiology of unstable coronary artery disease.

作者信息

Kristensen S D, Ravn H B, Falk E

机构信息

Department of Cardiology and Institute of Experimental Clinical Research, Skejby Hospital, Aarhus N, Denmark.

出版信息

Am J Cardiol. 1997 Sep 4;80(5A):5E-9E. doi: 10.1016/s0002-9149(97)00482-7.

DOI:10.1016/s0002-9149(97)00482-7
PMID:9296462
Abstract

Coronary atherosclerosis without thrombosis is, in general, a benign disease. However, plaque disruption, or fissuring, with superimposed thrombosis, frequently complicates the course of coronary atherosclerosis. Small ruptures often remain clinically silent, whereas more extensive plaque rupture may cause the development of unstable angina, myocardial infarction, and sudden death. The risk of plaque disruption depends more on plaque type (composition) than on plaque size and stenosis severity. Major determinants of a plaque's vulnerability to rupture are: the size and consistency of the lipid-rich atheromatous core; the thickness of the fibrous cap covering the core; and ongoing inflammation and repair within the cap. Both plaque vulnerability (intrinsic disease) and rupture triggers (extrinsic forces) are important for plaque disruption. The former predisposes the plaque to rupture whereas the latter may precipitate it. The resultant thrombotic response, which is important for the clinical presentation and outcome, is portly determined by the reactivity of the circulating platelets and the balance between the fibrinolytic and coagulation systems. New ways of identification and treatment of the dangerous vulnerable plaques responsible for infarction and death, and optimization of antithrombotic treatment, are highly warranted in order to prevent and treat life-threatening coronary thrombosis.

摘要

一般来说,无血栓形成的冠状动脉粥样硬化是一种良性疾病。然而,斑块破裂或裂隙伴血栓形成常常使冠状动脉粥样硬化的病程复杂化。小的破裂通常在临床上没有症状,而更广泛的斑块破裂可能导致不稳定型心绞痛、心肌梗死和猝死。斑块破裂的风险更多地取决于斑块类型(成分),而非斑块大小和狭窄严重程度。斑块易破裂的主要决定因素包括:富含脂质的粥样硬化核心的大小和稠度;覆盖核心的纤维帽的厚度;以及帽内持续的炎症和修复。斑块易损性(内在疾病)和破裂触发因素(外在力量)对于斑块破裂都很重要。前者使斑块易于破裂,而后者可能促使其发生破裂。所产生的血栓形成反应对于临床表现和预后很重要,很大程度上由循环血小板的反应性以及纤溶系统和凝血系统之间的平衡所决定。为了预防和治疗危及生命的冠状动脉血栓形成,极有必要采用新的方法来识别和治疗导致梗死和死亡的危险易损斑块,并优化抗血栓治疗。

相似文献

1
Insights into the pathophysiology of unstable coronary artery disease.对不稳定型冠状动脉疾病病理生理学的见解
Am J Cardiol. 1997 Sep 4;80(5A):5E-9E. doi: 10.1016/s0002-9149(97)00482-7.
2
What an interventional cardiologist should know about the pathophysiology of acute myocardial infarction.介入心脏病学家应了解的急性心肌梗死病理生理学知识。
Semin Interv Cardiol. 1999 Mar;4(1):11-6.
3
Atherosclerosis and acute coronary events.
Am J Cardiol. 1998 Nov 26;82(10B):37T-40T. doi: 10.1016/s0002-9149(98)00721-8.
4
Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.急性冠状动脉综合征发病机制中的斑块病理学与冠状动脉血栓形成
Scand J Clin Lab Invest Suppl. 1999;230:3-11.
5
Vulnerable and dangerous coronary plaques.
Atherosclerosis. 1995 Dec;118 Suppl:S141-9.
6
Role of inflammation and metalloproteinases in plaque disruption and thrombosis.炎症和金属蛋白酶在斑块破裂和血栓形成中的作用。
Vasc Med. 1998;3(3):199-206. doi: 10.1177/1358836X9800300304.
7
Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.冠状动脉斑块侵蚀,未破裂进入脂质核心。是心源性猝死中冠状动脉血栓形成的常见原因。
Circulation. 1996 Apr 1;93(7):1354-63. doi: 10.1161/01.cir.93.7.1354.
8
Coronary atherosclerosis: determinants of plaque rupture.冠状动脉粥样硬化:斑块破裂的决定因素。
Eur Heart J. 1998 Apr;19 Suppl C:C24-9.
9
Pathophysiology and inflammatory aspects of plaque rupture.
Cardiol Clin. 1996 May;14(2):211-20. doi: 10.1016/s0733-8651(05)70274-5.
10
Plaque disruption and coronary thrombosis: new insight into pathogenesis and prevention.斑块破裂与冠状动脉血栓形成:发病机制与预防的新见解
Clin Cardiol. 1997 Nov;20(11 Suppl 2):II-38-44.

引用本文的文献

1
The role of microparticles in oxidative stress and inflammation in patients with vascular intimal hyperplasia.微粒在血管内膜增生患者氧化应激和炎症中的作用。
J Int Med Res. 2025 Aug;53(8):3000605251364781. doi: 10.1177/03000605251364781. Epub 2025 Aug 12.
2
Vascular damage effect of circulating microparticles in patients with ACS is aggravated by type 2 diabetes.2 型糖尿病加重 ACS 患者循环微粒体的血管损伤效应。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12113. Epub 2021 Apr 26.
3
Cell therapy for myocardial infarction.
心肌梗死的细胞治疗。
Int J Stem Cells. 2010 May;3(1):8-15. doi: 10.15283/ijsc.2010.3.1.8.
4
Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation.动脉粥样硬化的小鼠模型:解释脂质代谢和炎症的关键作用。
J Appl Genet. 2013 May;54(2):185-92. doi: 10.1007/s13353-013-0134-4. Epub 2013 Jan 30.
5
Targeting the vulnerable plaque: the evolving role of nuclear imaging.靶向易损斑块:核成像的不断演变的作用。
J Nucl Cardiol. 2005 Mar-Apr;12(2):234-46. doi: 10.1016/j.nuclcard.2005.01.008.
6
Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides.用锝-99m标记的反义寡核苷酸对动脉粥样硬化斑块进行分子成像。
Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):6-14. doi: 10.1007/s00259-004-1700-0. Epub 2004 Nov 26.
7
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).依替巴肽治疗急性冠脉综合征的效果:早期与晚期给药——对血小板的治疗效果(早期血小板亚研究)
J Thromb Thrombolysis. 2002 Dec;14(3):213-9. doi: 10.1023/a:1025048726396.
8
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.依替巴肽:急性冠脉综合征患者和/或接受经皮冠状动脉介入治疗患者应用综述
Drugs. 1999 Mar;57(3):439-62. doi: 10.2165/00003495-199957030-00015.
9
[Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention].
Herz. 1998 May;23(3):193-6. doi: 10.1007/BF03044605.